Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Surgical Wound Infection | 52 | 2024 | 1530 | 7.460 |
Why?
|
Hernia, Ventral | 21 | 2024 | 218 | 6.630 |
Why?
|
Surgical Mesh | 20 | 2022 | 311 | 5.390 |
Why?
|
Surgical Procedures, Operative | 52 | 2021 | 1923 | 4.790 |
Why?
|
Hospitals, Veterans | 45 | 2024 | 395 | 4.770 |
Why?
|
United States Department of Veterans Affairs | 38 | 2022 | 930 | 4.090 |
Why?
|
Antibiotic Prophylaxis | 19 | 2020 | 637 | 2.720 |
Why?
|
Hernia, Inguinal | 13 | 2024 | 220 | 2.490 |
Why?
|
Soft Tissue Infections | 7 | 2020 | 168 | 2.450 |
Why?
|
Postoperative Complications | 65 | 2021 | 15637 | 2.220 |
Why?
|
Ambulatory Surgical Procedures | 14 | 2021 | 463 | 2.180 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 10 | 2021 | 696 | 1.780 |
Why?
|
Vancomycin | 15 | 2020 | 503 | 1.780 |
Why?
|
Hernia, Abdominal | 6 | 2024 | 56 | 1.760 |
Why?
|
Quality Indicators, Health Care | 22 | 2018 | 1789 | 1.580 |
Why?
|
Anti-Infective Agents, Local | 6 | 2017 | 247 | 1.550 |
Why?
|
Colorectal Surgery | 7 | 2020 | 122 | 1.490 |
Why?
|
Oxazolidinones | 8 | 2012 | 98 | 1.430 |
Why?
|
Anti-Infective Agents | 8 | 2019 | 983 | 1.390 |
Why?
|
Biofilms | 4 | 2018 | 625 | 1.330 |
Why?
|
Acetamides | 8 | 2012 | 257 | 1.320 |
Why?
|
Laparoscopy | 20 | 2024 | 2035 | 1.280 |
Why?
|
Preoperative Care | 11 | 2020 | 2241 | 1.210 |
Why?
|
Digestive System Surgical Procedures | 7 | 2021 | 571 | 1.200 |
Why?
|
Patient Readmission | 17 | 2021 | 3265 | 1.200 |
Why?
|
Staphylococcus aureus | 6 | 2018 | 1450 | 1.200 |
Why?
|
General Surgery | 14 | 2021 | 1693 | 1.190 |
Why?
|
Research Design | 15 | 2023 | 6180 | 1.180 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 2 | 2018 | 40 | 1.160 |
Why?
|
Veterans | 15 | 2022 | 2656 | 1.160 |
Why?
|
Antisepsis | 3 | 2016 | 16 | 1.130 |
Why?
|
Skin Diseases, Bacterial | 4 | 2014 | 67 | 1.130 |
Why?
|
Appendiceal Neoplasms | 2 | 2019 | 155 | 1.120 |
Why?
|
Medical Errors | 14 | 2018 | 1263 | 1.080 |
Why?
|
Veterans Health | 6 | 2022 | 215 | 1.050 |
Why?
|
Staphylococcal Infections | 9 | 2020 | 1401 | 0.990 |
Why?
|
Quality Assurance, Health Care | 13 | 2021 | 2164 | 0.910 |
Why?
|
Anti-Bacterial Agents | 25 | 2024 | 7407 | 0.890 |
Why?
|
Surgicenters | 2 | 2016 | 50 | 0.880 |
Why?
|
Intraoperative Complications | 4 | 2018 | 1164 | 0.870 |
Why?
|
Safety Management | 11 | 2011 | 761 | 0.850 |
Why?
|
United States | 102 | 2024 | 72341 | 0.810 |
Why?
|
Appendicitis | 2 | 2019 | 676 | 0.810 |
Why?
|
Staphylococcal Skin Infections | 4 | 2012 | 78 | 0.790 |
Why?
|
beta-Lactams | 6 | 2017 | 156 | 0.790 |
Why?
|
Cefotetan | 5 | 2008 | 6 | 0.760 |
Why?
|
Humans | 254 | 2024 | 761222 | 0.750 |
Why?
|
Cross Infection | 6 | 2018 | 1422 | 0.750 |
Why?
|
Negative-Pressure Wound Therapy | 2 | 2020 | 156 | 0.750 |
Why?
|
Abdominal Wall | 3 | 2019 | 166 | 0.730 |
Why?
|
Guidelines as Topic | 6 | 2021 | 1385 | 0.720 |
Why?
|
Quality Improvement | 11 | 2021 | 3808 | 0.720 |
Why?
|
Length of Stay | 15 | 2021 | 6417 | 0.700 |
Why?
|
Benchmarking | 3 | 2022 | 1045 | 0.680 |
Why?
|
Operating Rooms | 4 | 2020 | 790 | 0.660 |
Why?
|
Cathartics | 3 | 2012 | 126 | 0.650 |
Why?
|
Foreign Medical Graduates | 2 | 2011 | 77 | 0.650 |
Why?
|
Perioperative Care | 6 | 2017 | 1037 | 0.630 |
Why?
|
Quality Control | 1 | 2021 | 833 | 0.620 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.600 |
Why?
|
Program Evaluation | 3 | 2024 | 2489 | 0.600 |
Why?
|
Practice Guidelines as Topic | 11 | 2020 | 7400 | 0.590 |
Why?
|
Recurrence | 19 | 2022 | 8457 | 0.590 |
Why?
|
Retrospective Studies | 75 | 2021 | 80675 | 0.570 |
Why?
|
Surgical Stomas | 1 | 2017 | 42 | 0.560 |
Why?
|
Disinfection | 2 | 2020 | 207 | 0.560 |
Why?
|
Abdominal Injuries | 1 | 2020 | 361 | 0.560 |
Why?
|
Ultrasonic Therapy | 1 | 2018 | 215 | 0.550 |
Why?
|
Randomized Controlled Trials as Topic | 12 | 2022 | 10218 | 0.540 |
Why?
|
Surgery Department, Hospital | 2 | 2014 | 176 | 0.540 |
Why?
|
Guideline Adherence | 6 | 2024 | 2220 | 0.520 |
Why?
|
Infection Control | 7 | 2020 | 983 | 0.520 |
Why?
|
Device Removal | 1 | 2021 | 629 | 0.520 |
Why?
|
Urinary Tract Infections | 2 | 2020 | 801 | 0.480 |
Why?
|
Consensus | 5 | 2022 | 3134 | 0.480 |
Why?
|
Treatment Outcome | 48 | 2023 | 64681 | 0.470 |
Why?
|
Colectomy | 4 | 2012 | 686 | 0.470 |
Why?
|
Medical Staff, Hospital | 2 | 2016 | 601 | 0.460 |
Why?
|
Risk Management | 1 | 2018 | 557 | 0.460 |
Why?
|
Clinical Trials as Topic | 6 | 2017 | 8002 | 0.460 |
Why?
|
Seroma | 3 | 2012 | 73 | 0.460 |
Why?
|
Male | 134 | 2024 | 360703 | 0.450 |
Why?
|
Personnel Staffing and Scheduling | 6 | 2020 | 495 | 0.450 |
Why?
|
Postoperative Period | 4 | 2021 | 1818 | 0.450 |
Why?
|
Middle Aged | 105 | 2021 | 220858 | 0.450 |
Why?
|
Internship and Residency | 17 | 2020 | 5885 | 0.440 |
Why?
|
Delphi Technique | 7 | 2022 | 848 | 0.440 |
Why?
|
Cholecystitis, Acute | 2 | 2012 | 75 | 0.440 |
Why?
|
Stents | 9 | 2017 | 3177 | 0.440 |
Why?
|
Colony Count, Microbial | 3 | 2018 | 328 | 0.430 |
Why?
|
Aged | 96 | 2021 | 169292 | 0.430 |
Why?
|
Clostridium Infections | 5 | 2019 | 557 | 0.430 |
Why?
|
International Cooperation | 3 | 2011 | 1423 | 0.420 |
Why?
|
Adrenergic beta-Antagonists | 4 | 2017 | 1241 | 0.420 |
Why?
|
Cholecystostomy | 1 | 2012 | 48 | 0.400 |
Why?
|
Validation Studies as Topic | 2 | 2017 | 162 | 0.400 |
Why?
|
Female | 125 | 2021 | 392552 | 0.400 |
Why?
|
Nasopharyngeal Diseases | 1 | 2011 | 26 | 0.390 |
Why?
|
Medically Underserved Area | 2 | 2011 | 254 | 0.380 |
Why?
|
Methicillin Resistance | 4 | 2006 | 198 | 0.380 |
Why?
|
Risk Factors | 55 | 2024 | 74241 | 0.380 |
Why?
|
Urology | 1 | 2016 | 400 | 0.370 |
Why?
|
History, 21st Century | 5 | 2017 | 1567 | 0.370 |
Why?
|
Incidence | 17 | 2021 | 21366 | 0.360 |
Why?
|
Iatrogenic Disease | 2 | 2011 | 539 | 0.360 |
Why?
|
Acrospiroma | 1 | 2010 | 11 | 0.360 |
Why?
|
Cholecystectomy | 2 | 2012 | 404 | 0.350 |
Why?
|
Quality of Health Care | 10 | 2020 | 4321 | 0.350 |
Why?
|
Clinical Competence | 9 | 2021 | 4788 | 0.350 |
Why?
|
Ethanol | 1 | 2016 | 1322 | 0.350 |
Why?
|
Critical Pathways | 1 | 2013 | 475 | 0.340 |
Why?
|
Patient Admission | 2 | 2016 | 1365 | 0.330 |
Why?
|
Pneumonia | 2 | 2020 | 2142 | 0.330 |
Why?
|
Efficiency, Organizational | 2 | 2013 | 695 | 0.330 |
Why?
|
History, 20th Century | 6 | 2017 | 2765 | 0.330 |
Why?
|
Cost-Benefit Analysis | 5 | 2020 | 5493 | 0.330 |
Why?
|
Hospitalization | 8 | 2022 | 10707 | 0.330 |
Why?
|
Population Surveillance | 2 | 2010 | 2598 | 0.320 |
Why?
|
Clinical Coding | 9 | 2013 | 181 | 0.320 |
Why?
|
Cholecystectomy, Laparoscopic | 2 | 2010 | 231 | 0.320 |
Why?
|
Gallbladder Diseases | 1 | 2010 | 139 | 0.320 |
Why?
|
Communicable Diseases | 1 | 2017 | 873 | 0.320 |
Why?
|
Sepsis | 3 | 2020 | 2585 | 0.320 |
Why?
|
Biomedical Research | 3 | 2017 | 3434 | 0.320 |
Why?
|
Sweat Gland Neoplasms | 1 | 2010 | 116 | 0.320 |
Why?
|
Cohort Studies | 25 | 2024 | 41496 | 0.310 |
Why?
|
Hernia, Umbilical | 2 | 2022 | 102 | 0.310 |
Why?
|
Work Schedule Tolerance | 4 | 2020 | 553 | 0.300 |
Why?
|
Nasal Mucosa | 1 | 2011 | 413 | 0.300 |
Why?
|
Rectal Diseases | 1 | 2009 | 142 | 0.300 |
Why?
|
Acute Kidney Injury | 5 | 2019 | 1923 | 0.300 |
Why?
|
Collagen | 3 | 2012 | 2635 | 0.300 |
Why?
|
Education, Medical, Graduate | 7 | 2020 | 2374 | 0.290 |
Why?
|
Surgical Wound Dehiscence | 4 | 2013 | 212 | 0.290 |
Why?
|
Registries | 1 | 2024 | 8246 | 0.290 |
Why?
|
Arthroplasty, Replacement, Hip | 4 | 2019 | 1413 | 0.290 |
Why?
|
Colonic Diseases | 1 | 2009 | 201 | 0.290 |
Why?
|
Educational Measurement | 3 | 2007 | 1250 | 0.290 |
Why?
|
Logistic Models | 16 | 2019 | 13249 | 0.280 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2015 | 940 | 0.280 |
Why?
|
Arthroplasty, Replacement, Knee | 3 | 2019 | 1394 | 0.280 |
Why?
|
Comparative Effectiveness Research | 1 | 2012 | 708 | 0.280 |
Why?
|
Myocardial Revascularization | 6 | 2017 | 794 | 0.270 |
Why?
|
Workload | 5 | 2014 | 845 | 0.270 |
Why?
|
Faculty, Medical | 3 | 2016 | 1205 | 0.270 |
Why?
|
Time | 1 | 2008 | 545 | 0.260 |
Why?
|
Skin | 3 | 2020 | 4473 | 0.260 |
Why?
|
Skin Diseases, Infectious | 1 | 2006 | 76 | 0.260 |
Why?
|
Methicillin | 1 | 2005 | 62 | 0.250 |
Why?
|
Appendectomy | 2 | 2019 | 434 | 0.250 |
Why?
|
Abscess | 2 | 2019 | 605 | 0.250 |
Why?
|
Injections, Intravenous | 4 | 2016 | 1376 | 0.240 |
Why?
|
Ego | 1 | 2005 | 98 | 0.240 |
Why?
|
Patient Care | 3 | 2009 | 623 | 0.240 |
Why?
|
Postoperative Care | 4 | 2017 | 1468 | 0.240 |
Why?
|
Mortality | 1 | 2016 | 2896 | 0.240 |
Why?
|
Terminology as Topic | 3 | 2020 | 1528 | 0.240 |
Why?
|
Bacterial Infections | 2 | 2010 | 1390 | 0.240 |
Why?
|
Vascular Surgical Procedures | 7 | 2017 | 1489 | 0.230 |
Why?
|
Societies, Medical | 3 | 2020 | 3923 | 0.230 |
Why?
|
Diabetes Complications | 4 | 2016 | 1316 | 0.230 |
Why?
|
Biocompatible Materials | 1 | 2012 | 1683 | 0.230 |
Why?
|
Databases, Factual | 6 | 2024 | 7965 | 0.230 |
Why?
|
Time Factors | 23 | 2020 | 39957 | 0.220 |
Why?
|
Mentors | 2 | 2021 | 663 | 0.210 |
Why?
|
Phosphates | 1 | 2007 | 763 | 0.210 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1780 | 0.210 |
Why?
|
Follow-Up Studies | 14 | 2020 | 39127 | 0.210 |
Why?
|
Leadership | 2 | 2020 | 1385 | 0.210 |
Why?
|
Aged, 80 and over | 24 | 2021 | 58952 | 0.200 |
Why?
|
Prospective Studies | 17 | 2024 | 54437 | 0.200 |
Why?
|
Protective Clothing | 2 | 2020 | 103 | 0.200 |
Why?
|
Wound Healing | 5 | 2020 | 2800 | 0.200 |
Why?
|
Patient Care Team | 1 | 2013 | 2515 | 0.200 |
Why?
|
United States Agency for Healthcare Research and Quality | 2 | 2012 | 85 | 0.200 |
Why?
|
Risk Assessment | 15 | 2021 | 24022 | 0.200 |
Why?
|
Rectum | 4 | 2013 | 891 | 0.200 |
Why?
|
Administration, Oral | 5 | 2016 | 4015 | 0.200 |
Why?
|
Risk Adjustment | 4 | 2015 | 601 | 0.190 |
Why?
|
Streptococcal Infections | 1 | 2006 | 617 | 0.190 |
Why?
|
Adult | 51 | 2021 | 221120 | 0.190 |
Why?
|
Propensity Score | 4 | 2024 | 1916 | 0.190 |
Why?
|
Health Care Costs | 3 | 2010 | 3239 | 0.190 |
Why?
|
Predictive Value of Tests | 18 | 2017 | 15308 | 0.190 |
Why?
|
Hospital Mortality | 8 | 2020 | 5295 | 0.190 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 1187 | 0.180 |
Why?
|
Informed Consent | 3 | 2014 | 1008 | 0.180 |
Why?
|
New England | 1 | 2024 | 1052 | 0.180 |
Why?
|
Patients | 3 | 2021 | 906 | 0.180 |
Why?
|
Medicare | 9 | 2021 | 6774 | 0.180 |
Why?
|
Hysterectomy | 2 | 2018 | 857 | 0.180 |
Why?
|
Health Services Research | 10 | 2011 | 1807 | 0.180 |
Why?
|
Multivariate Analysis | 10 | 2017 | 12052 | 0.180 |
Why?
|
False Positive Reactions | 9 | 2011 | 958 | 0.180 |
Why?
|
Patient Discharge | 6 | 2020 | 3441 | 0.170 |
Why?
|
Abdominal Cavity | 1 | 2020 | 34 | 0.170 |
Why?
|
Colon | 4 | 2013 | 1791 | 0.170 |
Why?
|
Chlorhexidine | 2 | 2011 | 160 | 0.170 |
Why?
|
Retirement | 1 | 2021 | 197 | 0.160 |
Why?
|
Abdominal Muscles | 1 | 2020 | 169 | 0.160 |
Why?
|
Drug Resistance, Microbial | 2 | 2017 | 826 | 0.160 |
Why?
|
Morbidity | 2 | 2018 | 1751 | 0.160 |
Why?
|
Radionuclide Ventriculography | 1 | 1998 | 40 | 0.160 |
Why?
|
Professional Competence | 1 | 2002 | 430 | 0.160 |
Why?
|
Cerebrovascular Disorders | 2 | 2017 | 1474 | 0.160 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3770 | 0.160 |
Why?
|
Civil Defense | 1 | 2020 | 115 | 0.160 |
Why?
|
Patient Selection | 4 | 2016 | 4246 | 0.160 |
Why?
|
Thallium Radioisotopes | 1 | 1998 | 139 | 0.160 |
Why?
|
Abdomen | 2 | 2020 | 1128 | 0.160 |
Why?
|
Dipyridamole | 1 | 1998 | 142 | 0.160 |
Why?
|
Myocardial Infarction | 8 | 2017 | 11476 | 0.150 |
Why?
|
Bacteriuria | 1 | 2019 | 102 | 0.150 |
Why?
|
Decision Making | 1 | 2012 | 3931 | 0.150 |
Why?
|
Medical Records | 3 | 2020 | 1409 | 0.150 |
Why?
|
Hospitals | 4 | 2019 | 3881 | 0.150 |
Why?
|
Sonication | 1 | 2018 | 79 | 0.150 |
Why?
|
Pain, Postoperative | 2 | 2019 | 1741 | 0.150 |
Why?
|
Bioprosthesis | 2 | 2012 | 591 | 0.150 |
Why?
|
Multicenter Studies as Topic | 2 | 2012 | 1702 | 0.140 |
Why?
|
Attitude of Health Personnel | 6 | 2016 | 3885 | 0.140 |
Why?
|
Delivery of Health Care | 4 | 2022 | 5333 | 0.140 |
Why?
|
Chi-Square Distribution | 4 | 2012 | 3418 | 0.140 |
Why?
|
Acute Disease | 4 | 2019 | 7226 | 0.140 |
Why?
|
Hepatitis B, Chronic | 1 | 2021 | 410 | 0.140 |
Why?
|
Algorithms | 8 | 2020 | 14025 | 0.140 |
Why?
|
Angiography | 2 | 1993 | 1597 | 0.140 |
Why?
|
Comprehension | 2 | 2014 | 619 | 0.140 |
Why?
|
Anemia | 2 | 2017 | 1504 | 0.140 |
Why?
|
Operating Room Nursing | 1 | 2016 | 25 | 0.140 |
Why?
|
Abdominal Wound Closure Techniques | 1 | 2016 | 33 | 0.140 |
Why?
|
Liver Cirrhosis | 3 | 2022 | 1932 | 0.140 |
Why?
|
Societies, Scientific | 1 | 2017 | 223 | 0.130 |
Why?
|
Orbital Neoplasms | 1 | 1998 | 222 | 0.130 |
Why?
|
Career Choice | 2 | 2016 | 757 | 0.130 |
Why?
|
Vascular Diseases | 2 | 2009 | 1160 | 0.130 |
Why?
|
Infusions, Intravenous | 3 | 2012 | 2217 | 0.130 |
Why?
|
Coronary Vessels | 3 | 2017 | 3111 | 0.130 |
Why?
|
Common Bile Duct Diseases | 1 | 1995 | 36 | 0.130 |
Why?
|
Orthopedic Procedures | 2 | 2024 | 1276 | 0.130 |
Why?
|
Survival Rate | 6 | 2021 | 12728 | 0.130 |
Why?
|
Cholestasis, Extrahepatic | 1 | 1995 | 52 | 0.130 |
Why?
|
Pancreas | 2 | 1997 | 1684 | 0.130 |
Why?
|
Drug-Eluting Stents | 4 | 2014 | 681 | 0.130 |
Why?
|
Internal Medicine | 2 | 2014 | 1050 | 0.130 |
Why?
|
Obesity | 4 | 2017 | 12940 | 0.130 |
Why?
|
Tissue Scaffolds | 2 | 2012 | 932 | 0.130 |
Why?
|
Gentamicins | 1 | 2016 | 244 | 0.130 |
Why?
|
Proteinuria | 1 | 2018 | 605 | 0.120 |
Why?
|
Boston | 6 | 2018 | 9327 | 0.120 |
Why?
|
Orbit | 1 | 1998 | 457 | 0.120 |
Why?
|
Community Health Services | 1 | 2020 | 655 | 0.120 |
Why?
|
End Stage Liver Disease | 1 | 2019 | 352 | 0.120 |
Why?
|
Odds Ratio | 6 | 2021 | 9652 | 0.120 |
Why?
|
Sutures | 1 | 2017 | 282 | 0.120 |
Why?
|
Carrier State | 1 | 2018 | 522 | 0.120 |
Why?
|
Medical Records Systems, Computerized | 8 | 2011 | 1191 | 0.120 |
Why?
|
Accreditation | 3 | 2014 | 473 | 0.120 |
Why?
|
Computer-Assisted Instruction | 1 | 2018 | 362 | 0.120 |
Why?
|
Disaster Planning | 1 | 2020 | 557 | 0.120 |
Why?
|
Checklist | 1 | 2021 | 828 | 0.120 |
Why?
|
Colorectal Neoplasms | 2 | 2007 | 6919 | 0.120 |
Why?
|
Blood Transfusion | 3 | 2017 | 1303 | 0.110 |
Why?
|
Publishing | 1 | 2021 | 832 | 0.110 |
Why?
|
Inpatients | 8 | 2011 | 2545 | 0.110 |
Why?
|
Administration, Topical | 1 | 2016 | 703 | 0.110 |
Why?
|
Comorbidity | 5 | 2017 | 10516 | 0.110 |
Why?
|
History, 19th Century | 1 | 2016 | 718 | 0.110 |
Why?
|
World Health Organization | 1 | 2020 | 1321 | 0.110 |
Why?
|
Cardiovascular Diseases | 5 | 2016 | 15521 | 0.110 |
Why?
|
Duodenum | 2 | 1987 | 491 | 0.110 |
Why?
|
Problem-Based Learning | 1 | 1997 | 356 | 0.110 |
Why?
|
Pulmonary Embolism | 3 | 2018 | 2571 | 0.110 |
Why?
|
Continuity of Patient Care | 3 | 2016 | 1069 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 920 | 0.110 |
Why?
|
Hospitals, Teaching | 3 | 2013 | 1155 | 0.110 |
Why?
|
Respiratory Insufficiency | 2 | 2012 | 1232 | 0.110 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2017 | 2746 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1598 | 0.100 |
Why?
|
Cefazolin | 1 | 2013 | 94 | 0.100 |
Why?
|
Prostheses and Implants | 1 | 2019 | 1273 | 0.100 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7865 | 0.100 |
Why?
|
Clinical Trials, Phase IV as Topic | 1 | 2012 | 29 | 0.100 |
Why?
|
Truth Disclosure | 1 | 2016 | 432 | 0.100 |
Why?
|
Patient Satisfaction | 4 | 2020 | 3453 | 0.100 |
Why?
|
Reproducibility of Results | 12 | 2018 | 20118 | 0.100 |
Why?
|
Swine | 2 | 2012 | 5909 | 0.100 |
Why?
|
Military Medicine | 1 | 2014 | 184 | 0.100 |
Why?
|
Biopsy, Needle | 1 | 1997 | 1624 | 0.100 |
Why?
|
Mass Screening | 3 | 2019 | 5426 | 0.100 |
Why?
|
Frail Elderly | 1 | 2017 | 766 | 0.100 |
Why?
|
Angina, Unstable | 1 | 2016 | 890 | 0.100 |
Why?
|
Demography | 1 | 2016 | 1641 | 0.100 |
Why?
|
Heart Arrest | 2 | 2014 | 1513 | 0.100 |
Why?
|
Aneurysm, Infected | 1 | 2012 | 82 | 0.100 |
Why?
|
Drug Therapy, Combination | 4 | 2017 | 6304 | 0.100 |
Why?
|
Hypersensitivity | 1 | 2020 | 1167 | 0.090 |
Why?
|
Pancreatic Neoplasms | 3 | 1999 | 5366 | 0.090 |
Why?
|
Multiple Trauma | 1 | 2014 | 370 | 0.090 |
Why?
|
Tissue Adhesions | 1 | 2012 | 218 | 0.090 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2012 | 1228 | 0.090 |
Why?
|
Postoperative Hemorrhage | 2 | 2013 | 416 | 0.090 |
Why?
|
Endpoint Determination | 1 | 2014 | 590 | 0.090 |
Why?
|
Venous Thrombosis | 2 | 2018 | 1304 | 0.090 |
Why?
|
Preoperative Period | 3 | 2019 | 551 | 0.090 |
Why?
|
Blast Injuries | 1 | 2014 | 322 | 0.090 |
Why?
|
Poisson Distribution | 1 | 2011 | 504 | 0.090 |
Why?
|
Equipment Design | 1 | 2018 | 3510 | 0.090 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15841 | 0.080 |
Why?
|
2-Propanol | 1 | 2010 | 28 | 0.080 |
Why?
|
Quinolones | 1 | 2013 | 378 | 0.080 |
Why?
|
Cystadenoma | 1 | 1990 | 79 | 0.080 |
Why?
|
Blood Loss, Surgical | 2 | 2013 | 637 | 0.080 |
Why?
|
Observer Variation | 6 | 2012 | 2610 | 0.080 |
Why?
|
American Heart Association | 1 | 2014 | 1043 | 0.080 |
Why?
|
Povidone-Iodine | 1 | 2010 | 55 | 0.080 |
Why?
|
Probability | 4 | 2008 | 2478 | 0.080 |
Why?
|
Hematoma | 2 | 2012 | 763 | 0.080 |
Why?
|
Communication | 2 | 2016 | 3872 | 0.080 |
Why?
|
Arteries | 2 | 1998 | 1121 | 0.080 |
Why?
|
Cross-Sectional Studies | 11 | 2015 | 26072 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2000 | 2915 | 0.080 |
Why?
|
Venous Thromboembolism | 2 | 2012 | 1869 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2018 | 1747 | 0.080 |
Why?
|
Health Personnel | 1 | 2023 | 3337 | 0.080 |
Why?
|
Health Facility Environment | 1 | 2009 | 32 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1201 | 0.080 |
Why?
|
Ultrasonography | 2 | 2019 | 5969 | 0.080 |
Why?
|
Hyperglycemia | 1 | 2017 | 1375 | 0.080 |
Why?
|
Pancreatitis | 1 | 1995 | 1081 | 0.080 |
Why?
|
Treatment Failure | 3 | 2016 | 2643 | 0.080 |
Why?
|
Case-Control Studies | 4 | 2016 | 22174 | 0.080 |
Why?
|
Analysis of Variance | 5 | 2010 | 6223 | 0.080 |
Why?
|
Pulmonary Atelectasis | 1 | 2009 | 143 | 0.080 |
Why?
|
Survival Analysis | 3 | 2011 | 10088 | 0.080 |
Why?
|
Data Mining | 1 | 2013 | 552 | 0.080 |
Why?
|
Emotions | 1 | 2020 | 2742 | 0.070 |
Why?
|
Review Literature as Topic | 1 | 2010 | 348 | 0.070 |
Why?
|
Abdominal Abscess | 1 | 2009 | 153 | 0.070 |
Why?
|
Income | 1 | 2016 | 1869 | 0.070 |
Why?
|
Ascites | 2 | 2022 | 338 | 0.070 |
Why?
|
Extremities | 1 | 1993 | 867 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2000 | 3594 | 0.070 |
Why?
|
Gangrene | 2 | 2004 | 91 | 0.070 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 590 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2000 | 4513 | 0.070 |
Why?
|
Specialties, Surgical | 2 | 2013 | 389 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2017 | 2075 | 0.070 |
Why?
|
International Classification of Diseases | 1 | 2013 | 915 | 0.070 |
Why?
|
Retreatment | 1 | 2009 | 598 | 0.070 |
Why?
|
Perception | 3 | 2021 | 1198 | 0.070 |
Why?
|
California | 1 | 2011 | 1431 | 0.070 |
Why?
|
Israel | 1 | 2009 | 718 | 0.070 |
Why?
|
Databases as Topic | 1 | 2009 | 473 | 0.070 |
Why?
|
Foreign Bodies | 1 | 2011 | 402 | 0.070 |
Why?
|
Aztreonam | 1 | 2006 | 10 | 0.070 |
Why?
|
Cattle | 1 | 2012 | 3818 | 0.070 |
Why?
|
Penicillanic Acid | 1 | 2006 | 41 | 0.070 |
Why?
|
Digestive System Neoplasms | 1 | 1986 | 83 | 0.070 |
Why?
|
Blood Vessels | 1 | 1992 | 1111 | 0.070 |
Why?
|
Catheterization, Central Venous | 1 | 2011 | 526 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1725 | 0.070 |
Why?
|
Pneumoperitoneum | 2 | 1997 | 46 | 0.060 |
Why?
|
Advisory Committees | 1 | 2010 | 788 | 0.060 |
Why?
|
Americas | 1 | 2005 | 110 | 0.060 |
Why?
|
Carcinoma | 1 | 1997 | 2330 | 0.060 |
Why?
|
Coronary Angiography | 2 | 2016 | 4507 | 0.060 |
Why?
|
Bacteria | 1 | 2016 | 2190 | 0.060 |
Why?
|
Anesthesia | 1 | 2016 | 1591 | 0.060 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1662 | 0.060 |
Why?
|
Evidence-Based Medicine | 2 | 2019 | 3691 | 0.060 |
Why?
|
Activities of Daily Living | 2 | 2012 | 2420 | 0.060 |
Why?
|
Jejunum | 1 | 1987 | 472 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2000 | 5783 | 0.060 |
Why?
|
Sex Factors | 2 | 2009 | 10553 | 0.060 |
Why?
|
New Zealand | 1 | 2005 | 358 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1720 | 0.060 |
Why?
|
Gastric Emptying | 1 | 1987 | 243 | 0.060 |
Why?
|
Military Personnel | 1 | 2014 | 1246 | 0.060 |
Why?
|
Pain Measurement | 2 | 2017 | 3549 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 970 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3200 | 0.060 |
Why?
|
Focus Groups | 1 | 2010 | 1413 | 0.060 |
Why?
|
Schools, Medical | 1 | 2011 | 878 | 0.060 |
Why?
|
Linear Models | 2 | 2011 | 5869 | 0.060 |
Why?
|
Awards and Prizes | 1 | 2008 | 362 | 0.060 |
Why?
|
Bile Duct Neoplasms | 1 | 1990 | 607 | 0.060 |
Why?
|
Heart Diseases | 1 | 2017 | 2795 | 0.060 |
Why?
|
Sensitivity and Specificity | 6 | 2018 | 14675 | 0.060 |
Why?
|
Asia | 1 | 2005 | 622 | 0.060 |
Why?
|
Leg Ulcer | 1 | 2004 | 71 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2003 | 33 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1999 | 4021 | 0.060 |
Why?
|
Emergency Treatment | 1 | 2007 | 495 | 0.060 |
Why?
|
Coronary Disease | 2 | 2016 | 5921 | 0.060 |
Why?
|
Ethics, Clinical | 1 | 2004 | 101 | 0.060 |
Why?
|
Adolescent | 10 | 2010 | 88300 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8642 | 0.060 |
Why?
|
Meta-Analysis as Topic | 1 | 2008 | 1381 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4014 | 0.050 |
Why?
|
Adenocarcinoma | 2 | 2000 | 6341 | 0.050 |
Why?
|
Anticoagulants | 3 | 2017 | 4795 | 0.050 |
Why?
|
Penicillins | 1 | 2006 | 403 | 0.050 |
Why?
|
Health Services Needs and Demand | 1 | 2011 | 1401 | 0.050 |
Why?
|
Intestinal Diseases | 1 | 2007 | 503 | 0.050 |
Why?
|
Hernia, Hiatal | 1 | 2024 | 90 | 0.050 |
Why?
|
Cholecystitis | 1 | 2003 | 180 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 4 | 2019 | 20588 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5426 | 0.050 |
Why?
|
Foot Diseases | 1 | 2003 | 148 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3805 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9458 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3245 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 17897 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 4851 | 0.050 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2009 | 1116 | 0.050 |
Why?
|
Medicaid | 1 | 2015 | 2813 | 0.050 |
Why?
|
Safety | 2 | 2007 | 1151 | 0.050 |
Why?
|
Gallbladder | 1 | 2003 | 308 | 0.050 |
Why?
|
Urinalysis | 1 | 2024 | 368 | 0.050 |
Why?
|
Drug Combinations | 3 | 2017 | 2048 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 1993 | 1920 | 0.050 |
Why?
|
False Negative Reactions | 2 | 2013 | 573 | 0.050 |
Why?
|
Confidence Intervals | 3 | 2014 | 2928 | 0.050 |
Why?
|
Body Mass Index | 2 | 2010 | 12952 | 0.050 |
Why?
|
Reference Values | 1 | 2008 | 4921 | 0.050 |
Why?
|
Personal Satisfaction | 1 | 2005 | 645 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2016 | 12341 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.040 |
Why?
|
Health Services Administration | 1 | 2020 | 63 | 0.040 |
Why?
|
Role | 1 | 2020 | 176 | 0.040 |
Why?
|
Coronary Artery Disease | 3 | 2016 | 6506 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6819 | 0.040 |
Why?
|
Lacerations | 2 | 2012 | 147 | 0.040 |
Why?
|
Epidemiologic Methods | 1 | 2004 | 1336 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2010 | 8519 | 0.040 |
Why?
|
Likelihood Functions | 2 | 2013 | 991 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2021 | 426 | 0.040 |
Why?
|
Medical Audit | 2 | 2012 | 452 | 0.040 |
Why?
|
Europe | 1 | 2005 | 3423 | 0.040 |
Why?
|
Prognosis | 5 | 2019 | 29688 | 0.040 |
Why?
|
Budgets | 1 | 2020 | 230 | 0.040 |
Why?
|
Liver Neoplasms | 2 | 1995 | 4310 | 0.040 |
Why?
|
Medication Reconciliation | 1 | 2020 | 153 | 0.040 |
Why?
|
Single-Blind Method | 2 | 2016 | 1577 | 0.040 |
Why?
|
Drug Costs | 1 | 2006 | 1183 | 0.040 |
Why?
|
Equipment and Supplies | 1 | 2020 | 273 | 0.040 |
Why?
|
Animals | 5 | 2012 | 168089 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2000 | 367 | 0.040 |
Why?
|
Age Factors | 3 | 2010 | 18384 | 0.040 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 1997 | 82 | 0.030 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2019 | 264 | 0.030 |
Why?
|
Electronic Health Records | 4 | 2017 | 4822 | 0.030 |
Why?
|
Lacrimal Apparatus | 1 | 1998 | 223 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12474 | 0.030 |
Why?
|
Regression Analysis | 1 | 2006 | 6345 | 0.030 |
Why?
|
Physicians | 2 | 2005 | 4584 | 0.030 |
Why?
|
Stomach Diseases | 1 | 1997 | 134 | 0.030 |
Why?
|
Injections, Intra-Articular | 1 | 2017 | 280 | 0.030 |
Why?
|
Socioeconomic Factors | 3 | 2017 | 7804 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3702 | 0.030 |
Why?
|
Gels | 1 | 2016 | 420 | 0.030 |
Why?
|
Reimbursement Mechanisms | 2 | 2014 | 667 | 0.030 |
Why?
|
Hospital Costs | 2 | 2014 | 947 | 0.030 |
Why?
|
Stroke | 3 | 2017 | 9721 | 0.030 |
Why?
|
Glucose | 1 | 1987 | 4342 | 0.030 |
Why?
|
Coloring Agents | 1 | 1997 | 561 | 0.030 |
Why?
|
Infusion Pumps, Implantable | 1 | 1995 | 158 | 0.030 |
Why?
|
Telemedicine | 2 | 2020 | 3051 | 0.030 |
Why?
|
Fatal Outcome | 3 | 2012 | 1838 | 0.030 |
Why?
|
Hematocrit | 1 | 2016 | 623 | 0.030 |
Why?
|
Afghanistan | 1 | 2014 | 77 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13367 | 0.030 |
Why?
|
Models, Statistical | 4 | 2014 | 5081 | 0.030 |
Why?
|
Helicobacter pylori | 1 | 1997 | 382 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2021 | 2697 | 0.030 |
Why?
|
Cause of Death | 1 | 2004 | 3688 | 0.030 |
Why?
|
Helicobacter Infections | 1 | 1997 | 392 | 0.030 |
Why?
|
Arthroplasty, Replacement | 1 | 2017 | 309 | 0.030 |
Why?
|
Hospital Records | 1 | 2013 | 93 | 0.030 |
Why?
|
Diatrizoate Meglumine | 1 | 1993 | 79 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 1997 | 447 | 0.030 |
Why?
|
Time and Motion Studies | 1 | 2013 | 143 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18222 | 0.030 |
Why?
|
Neomycin | 1 | 2012 | 92 | 0.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1995 | 506 | 0.030 |
Why?
|
Erythromycin | 1 | 2012 | 114 | 0.030 |
Why?
|
Afghan Campaign 2001- | 1 | 2014 | 298 | 0.030 |
Why?
|
Video Recording | 1 | 2018 | 965 | 0.030 |
Why?
|
Sentinel Surveillance | 1 | 2014 | 291 | 0.030 |
Why?
|
Health Care Reform | 2 | 2014 | 1247 | 0.030 |
Why?
|
Insulin | 1 | 1987 | 6588 | 0.030 |
Why?
|
Thoracotomy | 1 | 1994 | 366 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 1997 | 1118 | 0.020 |
Why?
|
Specialty Boards | 1 | 2014 | 235 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 1995 | 1097 | 0.020 |
Why?
|
Feces | 1 | 2018 | 1490 | 0.020 |
Why?
|
Health Care Surveys | 2 | 2013 | 2425 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6067 | 0.020 |
Why?
|
Hyperthermia, Induced | 1 | 1995 | 417 | 0.020 |
Why?
|
Drainage | 1 | 2017 | 1157 | 0.020 |
Why?
|
Accidents | 1 | 2012 | 165 | 0.020 |
Why?
|
Thoracic Injuries | 1 | 1994 | 289 | 0.020 |
Why?
|
Metronidazole | 1 | 2012 | 232 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2928 | 0.020 |
Why?
|
Risk | 2 | 2013 | 9616 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2013 | 492 | 0.020 |
Why?
|
Fungemia | 1 | 2011 | 57 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3024 | 0.020 |
Why?
|
Triage | 1 | 2017 | 985 | 0.020 |
Why?
|
Aortography | 1 | 2012 | 421 | 0.020 |
Why?
|
Physician-Patient Relations | 2 | 2016 | 3253 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 6486 | 0.020 |
Why?
|
Coronary Thrombosis | 1 | 2013 | 440 | 0.020 |
Why?
|
Wounds, Penetrating | 1 | 2012 | 314 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1427 | 0.020 |
Why?
|
Ileum | 1 | 2012 | 557 | 0.020 |
Why?
|
Stomach Neoplasms | 2 | 1997 | 1457 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 1997 | 1122 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2182 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2017 | 1409 | 0.020 |
Why?
|
Home Care Services | 1 | 2016 | 647 | 0.020 |
Why?
|
Lung Injury | 1 | 1994 | 422 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 1997 | 1331 | 0.020 |
Why?
|
Wounds and Injuries | 2 | 2010 | 2493 | 0.020 |
Why?
|
Adenoma | 1 | 2000 | 2159 | 0.020 |
Why?
|
Curriculum | 1 | 2002 | 3741 | 0.020 |
Why?
|
Nose | 1 | 2012 | 521 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 2011 | 366 | 0.020 |
Why?
|
Blood Glucose | 2 | 2017 | 6392 | 0.020 |
Why?
|
Autopsy | 1 | 2012 | 1010 | 0.020 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2009 | 190 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1878 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2018 | 2092 | 0.020 |
Why?
|
Wounds, Gunshot | 1 | 1994 | 582 | 0.020 |
Why?
|
Mental Recall | 1 | 2014 | 1221 | 0.020 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1987 | 42 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2691 | 0.020 |
Why?
|
Patients' Rooms | 1 | 2007 | 62 | 0.020 |
Why?
|
Pneumothorax | 1 | 2010 | 386 | 0.020 |
Why?
|
Adenoma, Islet Cell | 1 | 1986 | 72 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2011 | 469 | 0.020 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2012 | 1425 | 0.020 |
Why?
|
Personnel, Hospital | 1 | 2009 | 285 | 0.020 |
Why?
|
Pyloric Antrum | 1 | 1986 | 66 | 0.020 |
Why?
|
Diabetic Foot | 1 | 2010 | 379 | 0.020 |
Why?
|
Pylorus | 1 | 1986 | 86 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2009 | 998 | 0.020 |
Why?
|
Methods | 1 | 1986 | 1063 | 0.020 |
Why?
|
Poverty | 1 | 2018 | 2691 | 0.020 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1986 | 120 | 0.020 |
Why?
|
Duodenal Neoplasms | 1 | 1986 | 114 | 0.020 |
Why?
|
Hernia | 1 | 2006 | 68 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11067 | 0.020 |
Why?
|
Ampulla of Vater | 1 | 1986 | 149 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2317 | 0.020 |
Why?
|
APACHE | 1 | 2006 | 267 | 0.020 |
Why?
|
Splenectomy | 1 | 1987 | 391 | 0.020 |
Why?
|
Oxygen | 1 | 2017 | 4228 | 0.020 |
Why?
|
Internet | 1 | 2018 | 3096 | 0.020 |
Why?
|
Hospitals, University | 1 | 2007 | 565 | 0.020 |
Why?
|
Serum Albumin | 1 | 2008 | 674 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2008 | 982 | 0.020 |
Why?
|
Hemorrhage | 1 | 2017 | 3422 | 0.010 |
Why?
|
Endarterectomy, Carotid | 1 | 2010 | 554 | 0.010 |
Why?
|
Students, Medical | 1 | 2018 | 1940 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4190 | 0.010 |
Why?
|
Sulbactam | 1 | 2003 | 31 | 0.010 |
Why?
|
Bacteremia | 1 | 2011 | 978 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 1987 | 1178 | 0.010 |
Why?
|
Ampicillin | 1 | 2003 | 136 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1998 | 12976 | 0.010 |
Why?
|
Rehabilitation | 1 | 2004 | 130 | 0.010 |
Why?
|
Anesthesiology | 1 | 2013 | 1122 | 0.010 |
Why?
|
Medication Adherence | 1 | 2014 | 2175 | 0.010 |
Why?
|
Leiomyosarcoma | 1 | 1986 | 422 | 0.010 |
Why?
|
Random Allocation | 1 | 1987 | 2393 | 0.010 |
Why?
|
Educational Status | 1 | 2010 | 2510 | 0.010 |
Why?
|
Dogs | 1 | 1987 | 3832 | 0.010 |
Why?
|
Prostatectomy | 1 | 2010 | 1825 | 0.010 |
Why?
|
Cardiology | 1 | 2013 | 1693 | 0.010 |
Why?
|
Chronic Disease | 1 | 1995 | 9319 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3320 | 0.010 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1115 | 0.010 |
Why?
|
Child, Preschool | 2 | 1993 | 42225 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2003 | 1597 | 0.010 |
Why?
|
Internationality | 1 | 2005 | 999 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2006 | 1723 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 59222 | 0.010 |
Why?
|
Sex Distribution | 1 | 2004 | 2277 | 0.010 |
Why?
|
Death | 1 | 2004 | 677 | 0.010 |
Why?
|
Psychometrics | 1 | 2009 | 3061 | 0.010 |
Why?
|
Leg | 1 | 2004 | 1087 | 0.010 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 1998 | 38 | 0.010 |
Why?
|
Age Distribution | 1 | 2004 | 2871 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2004 | 1936 | 0.010 |
Why?
|
Alcian Blue | 1 | 1997 | 13 | 0.010 |
Why?
|
Health Services | 1 | 2003 | 750 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2013 | 3627 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2003 | 1664 | 0.010 |
Why?
|
ROC Curve | 1 | 2004 | 3584 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 1997 | 362 | 0.010 |
Why?
|
Epirubicin | 1 | 1995 | 81 | 0.010 |
Why?
|
Lung | 1 | 1994 | 9979 | 0.010 |
Why?
|
Child | 3 | 1993 | 80154 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 1995 | 221 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1987 | 2244 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13511 | 0.010 |
Why?
|
Insurance, Health | 1 | 2007 | 2493 | 0.010 |
Why?
|
Mitomycin | 1 | 1995 | 263 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1995 | 11733 | 0.010 |
Why?
|
Angina Pectoris | 1 | 1998 | 959 | 0.010 |
Why?
|
Hepatic Artery | 1 | 1995 | 232 | 0.010 |
Why?
|
Hemothorax | 1 | 1994 | 58 | 0.010 |
Why?
|
Veins | 1 | 1998 | 767 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2007 | 3744 | 0.010 |
Why?
|
Microcirculation | 1 | 1998 | 1280 | 0.010 |
Why?
|
Health Surveys | 1 | 2003 | 4037 | 0.010 |
Why?
|
Mice | 1 | 2000 | 81330 | 0.010 |
Why?
|
Coronary Circulation | 1 | 1998 | 1611 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 10756 | 0.010 |
Why?
|
Laser Therapy | 1 | 1998 | 1094 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1998 | 36415 | 0.010 |
Why?
|
Emergencies | 1 | 1997 | 1217 | 0.010 |
Why?
|
Fluorouracil | 1 | 1995 | 1642 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 1998 | 2193 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 1998 | 2133 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 2003 | 5842 | 0.000 |
Why?
|
Platelet Count | 1 | 1987 | 782 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1995 | 2527 | 0.000 |
Why?
|
Autoantibodies | 1 | 1987 | 2119 | 0.000 |
Why?
|
Cell Survival | 1 | 1987 | 5778 | 0.000 |
Why?
|
Reoperation | 1 | 1987 | 4303 | 0.000 |
Why?
|
Blood Platelets | 1 | 1987 | 2477 | 0.000 |
Why?
|